Skip to content
AnalystLens

Idex Annual Report, Year Ended Dec 31, 2019

Filing Date
Filed February 21, 2020
Period End
December 31, 2019
Security
IEX
One revenue dollarkept$0.17
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’18Jan ’18
  2. Leadership change8-K · Sep ’22Sep ’22
  3. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 10-K filed February 21, 2020. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation's 2019 Form 10-K reports net sales of $2,494,573 thousanda ($2.49 billion), essentially flat versus $2,483,666 thousand in 2018, reflecting a 1% increase in organic sales and a 1% increase from acquisitions, offset by a 2% unfavorable foreign currency impact.

Operating income rose 2% to $579.0 millionb, with operating margin of 23.2%, up 30 basis points. Net income increased 4% to $425.5 million, and diluted EPS was $5.56, up $0.27 from $5.29. Excluding $21.0 million of restructuring expense and a $3.3 million fair value inventory step-up charge, adjusted operating income grew 4% to $603.4 million and adjusted EPS rose 7% to $5.80.

Cash flow from operations increased to $528.1 millionc, and cash and cash equivalents ended the year at $632.6 million, of which $350.9 million was held outside the United States. Capital expenditures were $50.9 million. The company repurchased $54.7 million of stock in 2019, versus $173.9 million in 2018, and had $322.3 million of repurchase authorization remaining.

Dividends declared rose to $2.00d per share from $1.72. The company acquired Velcora for $87.2 million in cash plus $51.1 million of assumed debt, which was later retired. Its $800.0 million revolving facility had no balance outstanding at year end, and total borrowings were $850.6 million, substantially all fixed rate.

Subsequent to year end, IDEX agreed on January 29, 2020 to acquire Flow Management Devices, LLC for $125 million in cash, with closing expected by the end of the first quarter of 2020. The filing also discloses a wind-down of one Health & Science Technologies business after the loss of its largest customer, which drove $9.7 million of impairment charges within restructuring expense.

Key Highlights

  1. Net sales of $2.49 billion were flat year over year; organic sales grew 1%, acquisitions added 1%, and foreign currency reduced sales by 2%.
  2. Operating income rose 2% to $579.0 million, and operating margin improved to 23.2% from 22.9%.
  3. Diluted EPS was $5.56 versus $5.29 in 2018; adjusted EPS was $5.80 versus $5.41.
  4. Operating cash flow increased to $528.1 million, and capital expenditures were $50.9 million.
  5. Cash and equivalents were $632.6 million at year end, and the $800.0 million revolver was undrawn.
  6. Dividends declared were $2.00 per share versus $1.72 in 2018, and share repurchases fell to $54.7 million from $173.9 million.
  7. Agreed in January 2020 to acquire Flow Management Devices, LLC for $125 million in cash, expected to close in the first quarter of 2020.

Follow one dollar

Of each $1.00 of revenue in FY2019, Idex kept $0.17.

  1. Revenue$2.49B100.0%
  2. Cost of revenue−$1.37B54.9%
  3. Gross profit$1.13B45.1%
  4. Operating costs−$546.0M21.9%
  5. Operating income$579.0M23.2%
  6. Interest, other & tax−$153.5M6.2%
  7. Net income$425.5M17.1%
Computed from 10-KFY2019filed February 21, 2020Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2019 revenue went

$2.49B
  • Cost of revenue: $1.37B, 55% of revenue
  • SG&A: $525.0M, 21% of revenue
  • Net income: $425.5M, 17% of revenue
  • R&D: $56.4M, 2.3% of revenue
  • Interest, other & tax: $153.5M, 6.2% of revenue

Kept 17% as net income

Full revenue history →

Financial Statements

FY2019 against FY2018

Line itemFY2019FY2018Change
Revenue$2.49B$2.48B+0.4%
Cost of Revenue$1.37B$1.37B+0.3%
Gross Profit$1.13B$1.12B+0.6%
R&D Expenses$56.40M$48.00M+17.5%
SG&A Expenses$525.00M$536.72M−2.2%
Operating Income$579.00M$569.09M+1.7%
Interest Expense$44.30M$44.13M+0.4%
Net Income$425.50M$410.57M+3.6%
EPS (Basic)$5.62$5.36+4.9%
EPS (Diluted)$5.56$5.29+5.1%
Shares Outstanding (Basic)75.60M76.41M−1.1%
Shares Outstanding (Diluted)76.50M77.56M−1.4%

Frequently Asked Questions

  1. How did IDEX perform financially in 2019?

    Net sales were $2,494,573 thousand, roughly flat versus 2018. Operating income increased 2% to $579.0 million, net income rose 4% to $425.5 million, and diluted EPS was $5.56, up from $5.29.

  2. What drove growth and what held it back?

    Organic sales grew 1% and acquisitions added 1%, while foreign currency translation reduced sales by 2%. Operating income growth was attributed to price capture, productivity initiatives and tighter cost controls, partially offset by inflation and sales mix.

  3. What restructuring and impairment charges affected 2019?

    Restructuring expenses totaled $21.0 million, including a $9.7 million impairment tied to winding down an HST business after it lost its largest customer, and a $0.4 million impairment from a facility consolidation. A $3.3 million fair value inventory step-up charge was also recorded from the Velcora acquisition.

  4. How is IDEX positioned financially and how is it returning capital?

    Year-end cash was $632.6 million, with $350.9 million held outside the U.S. Total borrowings were $850.6 million, substantially all fixed rate, and the revolver was undrawn. Dividends per share rose to $2.00, and $322.3 million of buyback authorization remained.

  5. What is the pending Flow Management Devices acquisition?

    On January 29, 2020, IDEX agreed to acquire Flow Management Devices, LLC, a provider of small volume provers for the oil and gas industry, for $125 million in cash. It will operate in the Fluid & Metering Technologies segment, and closing is expected by the end of the first quarter of 2020, subject to regulatory approvals.